Salicylic acid has been recognized for centuries for its medicinal properties in humans, harkening back to willow bark remedies and culminating in the widely used drug aspirin. Parallel to its role in human health, SA operates as a master immune regulator in plants, orchestrating complex defense responses against a broad spectrum of microbial invaders and pests. Plants rely on finely tuned SA signalling pathways to activate defenses precisely where and when needed, balancing immune activation with the imperative to sustain healthy growth. The ability to map this delicate trade-off in living tissues has long been a formidable challenge for plant scientists.

The research team, led by Dr. Alexander Jones at the Sainsbury Laboratory Cambridge University, has now surmounted this obstacle by creating SalicS1, a biosensor that detects changes in SA within plants with exceptional sensitivity and specificity. By fusing SA-responsive elements to fluorescent proteins, the sensor emits signals that reflect real-time fluctuations of SA concentration. This tool empowers researchers to visualize how SA accumulation begins locally at infection sites and then spreads outwards into adjacent cells and tissues, providing direct evidence of the hormone’s dynamic propagation during immune responses.

Previous methods to study SA involved destructive sampling and biochemical assays that could only provide static, averaged data, masking the spatial-temporal complexity of SA signalling. With SalicS1, scientists can monitor live plants undergoing pathogen invasion, witnessing bursts of SA that travel cell-to-cell. This insight is crucial for unraveling how plants integrate localized defense cues to coordinate systemic immunity—or systemic acquired resistance—effectively priming distant tissues for potential threats. Understanding these processes is vital for engineering crops that can resist diseases while minimizing growth penalties associated with chronic immune activation.

Dr. Jones explains that pathogens such as fungi, bacteria, viruses, and even insect pests have evolved sophisticated mechanisms to suppress SA signalling, thereby dampening plant immunity and facilitating infection. By applying SalicS1, researchers can now dissect these pathogen strategies in real time and determine how plants counteract immune suppression. This knowledge is expected to inform innovative approaches to crop protection, enabling breeders and biotechnologists to enhance disease resilience in agriculture sustainably.

The work also highlights the reversibility and non-invasive nature of the biosensor measurements, which is a major technical advancement. Unlike traditional techniques that disrupt tissues, SalicS1 allows continuous monitoring of living tissues without collateral damage. This capability will enable detailed studies on how environmental stresses—such as drought or temperature extremes—intersect with immune signalling pathways, offering a holistic view of how plants manage competing physiological demands.

Importantly, the implications of SalicS1 transcend plant biology. Given that salicylic acid is the core precursor molecule to aspirin, the most widely used pharmaceutical worldwide, a modified version of the biosensor that detects aspirin could be adapted to investigate aspirin metabolism and cellular pharmacodynamics in human cells. Such a crossover application has the potential to open new frontiers in medical research, bridging plant science and human health.

First author Dr. Bijun Tang emphasizes the dynamic and localized nature of SA signalling unveiled by SalicS1. The ability to capture hormone surges at sites of pathogen ingress reveals the precise timing and intensity of immune activation, details previously inferred but not directly observed. This represents a leap towards understanding the biochemical warfare between plants and their myriad antagonists at a cellular level, dramatically refining the conceptual model of plant-pathogen interactions.

The team’s discovery also mirrors broader biological questions relevant to animal health, such as variability in individual responses to infections. Dr. Jones draws parallels to the COVID-19 pandemic, where pathogen exposure led to dramatically different outcomes among humans. Similarly, plants exposed to identical inoculation conditions exhibit variable immune successes, partly explained now through differential SA signalling patterns observable with SalicS1.

Ultimately, these insights pave the way for novel agricultural strategies that harness precise immune modulation rather than broad-spectrum chemical treatments. By breeding or engineering crops that can dynamically deploy SA responses when and where necessary, it may become feasible to reduce pesticide usage, promote sustainable farming practices, and ensure food security in the face of mounting pathogen pressures exacerbated by climate change.

The research, published in Science, was a collaborative effort involving several institutions, with critical technical contributions from the Institute of Experimental Botany of the Czech Academy of Sciences. Funding support was provided by the Gatsby Charitable Foundation, the European Research Council, the Max Planck Society, and EMBO. As this innovative biosensor is adopted and refined, it promises to illuminate the hidden molecular choreography that underpins plant survival and resilience, inspiring a new era in both plant science and beyond.

Subject of Research: Cells

Article Title: SALICYLIC ACID SENSOR1 reveals the propagation of an SA hormone surge during plant pathogen advance

News Publication Date: 9-Oct-2025

Web References:
Science Journal
DOI: 10.1126/science.adw7650

References:
Tang, B., Lu, J., Leontovyčová, H., Hoffmann, G., Rowe, J.H., O’Donnell, S.F., Grangé-Guermente, M., Larsen, B., Wimalasekera, R., Carella, P., Incarbone, M., Kalachova, T., Jones, A.M. (2025). SALICYLIC ACID SENSOR1 reveals the propagation of an SA hormone surge during plant pathogen advance. Science. DOI: 10.1126/science.adw7650

Image Credits: Bijun Tang

Keywords: Salicylic acid, plant immunity, biosensor, SalicS1, pathogen defense, hormone signalling, systemic acquired resistance, plant-pathogen interactions, fluorescence sensor, crop resilience, aspirin metabolism, cellular dynamics

For decades, scientific understanding of CO₂’s fate in ocean waters has centered on the molecule’s dissolution deep within the bulk water phase, where it reacts with water to form carbonic acid. This acidification process plays a critical role in lowering the ocean’s pH and has far-reaching consequences for marine ecosystems, from coral bleaching to disrupting the food chain. However, previous research largely neglected the subtleties of what occurs at the thin, molecular interface between air and water—where the ocean’s surface meets the atmosphere.

The “In and Out” mechanism discovered by the Cambridge-UCL team reveals that CO₂ does not simply dissolve and diffuse uniformly throughout the water. Instead, the molecule temporarily penetrates just the topmost water layer, which is only a few molecules thick, where it rapidly reacts to form carbonic acid. After this fleeting interaction, the acid species returns to the surface and can disengage back into the air. This behavior contrasts vividly with prior models that assumed CO₂ must fully integrate into the ocean’s volume to undergo chemical transformation.

Samuel Brookes, a PhD student at Cambridge’s Yusuf Hamied Department of Chemistry and an author of the study, explained this process vividly: “Imagine CO₂ as a diver performing a quick dip into the water’s very top layer before reemerging—reacting while barely submerging.” The reaction, occurring in this constrained interfacial environment, effectively halves the energetic barrier expected from the denser, bulk water environment. The effect of this dynamic is a substantially faster formation rate of carbonic acid at the ocean’s surface, with profound implications for understanding how swiftly ocean acidification can advance.

One of the study’s most striking revelations is that the chemical energy barrier for CO₂ hydration at the interface remains comparable to, or even less than, that within the bulk solution. This defies conventional wisdom, which predicted that the limited number of water molecules at the surface would retard the reaction. The “In and Out” model clarifies that the peculiar dynamics at play, including CO₂ repeatedly entering and exiting the interface, compensate for the reduced hydration shell, enabling efficient chemistry.

To achieve these insights, the researchers employed cutting-edge machine learning algorithms integrated with quantum chemical calculations. This innovative approach allowed molecular-level simulations that revealed not only the mechanistic pathways but also detailed reaction energies and kinetics with unprecedented accuracy. By training models on high-fidelity quantum data, the team could track CO₂’s behavior at atomic scales, offering a window into an elusive but critical environmental process.

Beyond the fundamental scientific novelty, the findings underscore an urgent need to revisit and refine climate and ocean models. Current estimations of ocean acidification rates may be seriously underestimated if the rapid, interface-mediated CO₂ hydration process is not accounted for. Considering billions of tons of atmospheric CO₂ are absorbed annually, the new mechanism implies oceans could acidify faster, potentially exacerbating ecological damage sooner than anticipated.

The multidisciplinary team, led by Dr. Christoph Schran at Cambridge’s Cavendish Laboratory, noted how incredibly sensitive these reactions are to minuscule spatial changes. “Moving CO₂ by just a fraction of a nanometer—from above the surface to the topmost water molecules—almost halves the reaction energy barrier,” Schran reflected. Such striking spatial sensitivity raises broader scientific questions about other chemical and physical processes occurring at environmental interfaces, suggesting this might be a widespread phenomenon.

Looking forward, the researchers plan to extend their computational models to incorporate the myriad ions naturally present in seawater, such as sodium, chloride, and carbonate. Integrating these species is crucial for achieving simulations that mirror real-world oceanic conditions closely, which will enhance predictions of surface pH variations and further clarify chemical reactivity at interfaces. These expansions could reveal more nuanced pathways affecting ocean chemistry and help inform global climate mitigation strategies.

The study was supported by the Syntech Centre for Doctoral Training and funded by the EPSRC and European Union through the “n-AQUA” ERC project. Computational resources came from the UK Materials and Molecular Modeling Hub as well as the Car-Parrinello consortium. This collaborative effort represents a remarkable confluence of theoretical chemistry, advanced computation, and climate science.

Ultimately, this research not only enhances our understanding of an essential geochemical process but also exemplifies how machine learning and quantum chemistry can intersect to address urgent, real-world environmental challenges. The “In and Out” mechanism vividly redefines the microscopic life of CO₂ molecules at the ocean surface and signals a new era of exploring molecular phenomena at environmental interfaces.

Subject of Research: Hydration and chemical reaction of CO₂ at the air–water interface leading to carbonic acid formation
Article Title: CO2 hydration at the air–water interface: A surface-mediated “in-and-out” mechanism
News Publication Date: 20-Aug-2025
Web References: https://www.pnas.org/doi/10.1073/pnas.2502684122
References: Proceedings of the National Academy of Sciences
Image Credits: Photo by Nathan Pitt | Department of Chemistry, University of Cambridge

Keywords

Chemical physics, Chemical reactions, Physical chemistry

Recent breakthroughs by an international coalition of astronomers, spearheaded by the University of Cambridge, indicate a promising avenue for unraveling the characteristics of these first stars. Researchers propose that by examining a particular radio signal emitted by hydrogen atoms—located in the interstellar medium between star-forming regions—they can infer the masses and other attributes of these ancient stars. This signal, known as the 21-centimetre signal, is vital for understanding the conditions prevalent in the early universe, offering insights into how it evolved from a nearly uniform composition primarily consisting of hydrogen to the complex astronomical structures we observe today.

The 21-centimetre signal represents a faint, yet crucial, energy output from over 13 billion years ago, shaped significantly by the radiation produced by the universe’s first stars and black holes. By delving into how these early luminous entities and their remnants influenced the propagation of this radio signal, researchers anticipate that future radio telescopes will shed light on the origins and evolution of the universe. The work has been documented in the journal Nature Astronomy, highlighting the significance of this research in the broader context of cosmic evolution.

Professor Anastasia Fialkov from Cambridge’s Institute of Astronomy, a co-author of the study, emphasizes the importance of this research, stating, “This is a unique opportunity to learn how the universe’s first light emerged from the darkness.” The researchers believe that although our understanding is still nascent, each advancement brings us closer to comprehending the remarkable narrative of the cosmos transitioning from a cold, dark expanse into a vibrant universe filled with stars.

The investigation into the universe’s most ancient stars hinges prominently on the elusive 21-centimetre signal. Fialkov leads the theoretical group of REACH, the Radio Experiment for the Analysis of Cosmic Hydrogen, which aims to gather radio signals that can inform us about the Cosmic Dawn and the subsequent Epoch of Reionisation. This pivotal event involved the first stars reionizing neutral hydrogen atoms, enabling the universe to transition toward the luminous state filled with galaxies and stellar populations.

While the REACH telescope is currently undergoing calibration, its potential to glean data about the universe’s infancy is significant. Complementing this effort is the Square Kilometre Array (SKA), an ambitious project designed to map cosmic signals across vast tracts of sky. Both REACH and SKA are integral to enhancing our knowledge of the mass, luminosity, and distribution of the universe’s earliest stars.

Within this study, the research team led by Fialkov has developed a theoretical model predicting how the 21-centimetre signal is influenced by the mass distribution of these first-generation stars, classified as Population III stars. Their findings suggest that previous studies may have overlooked critical factors, including the number and brightness of X-ray binaries—binary systems consisting of a normal star paired with a collapsed star—and how these elements impact the 21-centimetre signal.

Unlike optical telescopes such as the James Webb Space Telescope, which can capture striking images of celestial objects, radio astronomy relies on the statistical analysis of faint signals, which provides a broader understanding of entire populations of stars, X-ray binary systems, and galaxies rather than individual stars. This technique necessitates a nuanced approach to connect the observations of radio signals with the overarching narrative of early star formation.

The implications of this research are profound. Dr. Eloy de Lera Acedo, Principal Investigator of the REACH telescope and a co-author of the study, articulates that the predictions arising from their findings could offer substantial insight into the nature of the universe’s first stars, which likely differed significantly from the stars that populate our cosmos today. He notes, "Radio telescopes like REACH are promising to unlock the mysteries of the infant Universe."

As the network of radio telescopes like REACH and SKA continues to evolve, the research community is poised to gather data that could significantly alter our comprehension of cosmic history. By investigating the early signals from the universe’s first stars, astronomers hope to consolidate a clearer timeline of cosmic evolution, filling in gaps about how the universe transitioned towards the complex web of galaxies, stars, and other cosmic structures we observe in the present epoch.

Ultimately, this research sheds light on the potential for future discoveries via radio astronomy that could unravel further mysteries about the universe’s early days, revealing how the connections between early astronomical phenomena have shaped the cosmos we inhabit now. As these advanced observational technologies come online, they are expected to bring us ever closer to answering fundamental questions about the evolution of the universe.

In summary, the revelations from this groundbreaking study signify not just the dawn of a new era in astronomy but also the continuous human endeavor to understand our place within the universe’s grand narrative. The synergy between theory and observation will likely play a crucial role in shaping our future knowledge about the cosmos.

Subject of Research: The properties and masses of the earliest stars in the universe through the study of the 21-centimetre signal.

Article Title: Determination of the mass distribution of the first stars from the 21-cm signal.

News Publication Date: 20-Jun-2025.

Web References: Nature Astronomy Article.

References: Information can be found in the referenced Nature Astronomy article.

Image Credits: N/A.

Keywords

Cosmic Dawn, 21-centimetre signal, Population III stars, REACH telescope, Square Kilometre Array, hydrogen atoms, early universe, radio astronomy, astrophysics, formation of stars.

Alkenes, defined by their characteristic double carbon-carbon bonds, serve as fundamental building blocks in organic chemistry. Found ubiquitously across pharmaceuticals, agrochemicals, and materials science, these molecules offer rich versatility. However, until now, the incremental extension of alkene chains by singular carbon atoms has posed significant challenges due to the multistep and laborious nature of traditional synthetic routes. The Cambridge team’s pioneering one-carbon homologation process elegantly circumvents these obstacles, enabling rapid, selective molecular augmentation.

At the heart of this transformation lies an ingenious chemical reagent—a cleverly designed allyl sulfone derivative functioning as a “one-carbon transfer agent.” This reagent facilitates a cascade whereby it initially covalently attaches to the alkene substrate, triggering a controlled sequence of bond reorganization. The reaction culminates in the integration of precisely one carbon atom into the substrate’s backbone. This process operates under mild conditions in a single pot, markedly reducing synthetic complexity and time investment compared to classical methods.

Professor Matthew Gaunt and Dr. Marcus Grocott, leading the Yusuf Hamied Department of Chemistry team, emphasize the conceptual novelty: “While alkenes are abundant and structurally important, a facile, selective route to insert just one carbon atom into these molecules remained elusive. Our reagent’s modular design confers unique control over both reactivity and selectivity.” The modularity is evident, as each segment of the reagent is tailored to execute a specific function, from substrate recognition and binding to initiation and termination of the carbon insertion sequence.

The versatility of this method is underscored by its compatibility with a broad array of alkene substrates, spanning diverse structural classes and functional groups. Such tolerance greatly expands the chemical space accessible through homologation, enabling chemists to traverse molecular architectures more creatively and efficiently than before. This expands not only synthetic toolbox but also strategic possibilities in pharmaceutical chemistry and beyond.

In a particularly compelling demonstration of practical utility, the team applied their technology to the immunosuppressive agent Cyclosporine A, a complex cyclic peptide widely used in transplant medicine. Through incremental addition of one or two carbons, they generated novel analogues which exhibited varied binding affinities and immunomodulatory activities. Intriguingly, some analogues maintained the capacity to bind target proteins and modulate immune response, while others selectively diminished immunosuppressive effects, suggesting pathways toward fine-tuned therapeutic modulation.

This precision editing at the molecular level exemplifies the transformative potential for medicinal chemistry. Fine control over molecular composition and length directly translates into modulation of pharmacodynamics and pharmacokinetics—critical factors in optimizing drug candidates. With the ability to explore “chemical space” with such granularity, chemists can now design drug analogues that might achieve enhanced efficacy, reduced toxicity, or tailored biological profiles.

Moreover, the route holds promise well beyond pharmaceuticals. In agrochemical design, subtle alterations to molecular carbon frameworks can dramatically influence properties such as bioavailability, environmental stability, and target specificity. Similarly, in materials science, precisely extended carbon chains can modulate polymer properties, influence surface interactions, and enhance functional performance. This methodology thus opens broad industrial avenues.

Underlying this advancement are sophisticated mechanistic insights into the dynamic behavior of the allyl sulfone reagent. Kinetic studies reveal how particular structural elements orchestrate the timing of bond formation and cleavage, ensuring high selectivity. The process is reminiscent of a precision molecular “assembly line,” where each step is choreographed to yield the desired product without side-reactions. This level of control is unparalleled in homologation chemistry.

The Cambridge team’s approach contrasts starkly with classical methods requiring multiple protective group manipulations, sequential functional group interconversions, and harsh reaction conditions. By embracing a catalytic, single-pot design, the methodology embodies the principles of green chemistry—minimizing waste, energy consumption, and procedural complexity. This aligns seamlessly with contemporary drives toward sustainable and scalable synthetic approaches.

Dr. Grocott reflects on the broader significance: “Our platform is more than a synthetic shortcut. It’s a conceptual leap that enables chemists to design and construct molecules with an extraordinary level of precision. This capability can accelerate not only the pace of discovery but also the depth of innovation across chemical disciplines.” Such statements underscore the paradigm shift embodied by this work.

The work’s timely publication in the journal Nature signals its exceptional impact on the scientific community. As researchers worldwide digest and adopt this technology, a cascade of novel synthetic strategies and applications is anticipated. Its integration into medicinal chemistry programs promises to expedite the translation of molecular designs from concept to clinical candidates, ever critical in an era demanding rapid response to emerging health challenges.

Ultimately, this advancement epitomizes the power of thoughtful molecular engineering, where design meets function to surmount longstanding obstacles. By granting chemists a robust, facile tool for one-carbon extension of alkenes, the Cambridge team has firmly positioned themselves at the vanguard of chemical innovation—opening a gateway to molecules previously deemed inaccessible and redefining the frontiers of chemical synthesis.

Subject of Research: Chemistry – One-carbon homologation of alkenes

Article Title: One-carbon homologation of alkenes

News Publication Date: 20-May-2025

Web References: https://www.nature.com/articles/s41586-025-09159-9

References: DOI: 10.1038/s41586-025-09159-9

Image Credits: Credit: Michael Webb

Keywords

Chemistry, Molecular chemistry, Molecules

The study, published in the journal Work, Employment and Society, represents the first survey-based statistical investigation into the quality of gig work in the UK. By gathering data from over 500 casual workers engaged in both local platform work—such as food delivery and ride-hailing—and remote platform work like coding and data entry, researchers were able to draw detailed comparisons between these distinct categories. The research reveals a striking disparity in job quality, pay, and wellbeing, particularly between those whose work is location-bound and those who operate in virtual spaces.

Central to the study’s findings is the emotional toll exacted by algorithmic management systems that govern gig work. Around two-thirds of riders and drivers reported fearing unfair feedback through app-based rating systems, which can lead abruptly to deactivation and loss of income. This digital form of surveillance and reputational control generates a persistent state of uncertainty, anxiety, and self-monitoring among workers. The psychological burden of these conditions cannot be overstated and highlights an important dimension of platform capitalism often overlooked in quantitative analyses.

Financial instability was another major concern among local gig workers. Three-quarters expressed anxiety about potential pay decreases, a figure substantially higher than that of remote gig workers. Average hourly wages for delivery drivers and riders stood at approximately £8, notably below the UK minimum wage of 2022, while remote workers earned an average of £10 per hour. This wage disparity underscores the economic vulnerability endemic to location-dependent platform labor, where income is contingent on physical presence, unpredictable demand, and algorithmically fluctuating pay rates.

Beyond financial pressures, the physical implications of local gig work were particularly stark. Over half of delivery riders and drivers reported risking their health and safety, a rate nearly five times greater than that among remote platform workers. A significant 42% of local platform workers suffered from physical pain directly linked to their work, indicating the toll of prolonged periods of intense manual labor—often under time pressure combined with insufficient rest. This chronic strain raises critical questions about occupational health standards and protections—or the lack thereof—in the gig economy.

Adding to their burdens, local platform workers also spent a substantial amount of time logged into apps without receiving work, effectively unpaid. On average, riders and drivers reported dedicating ten hours each week merely waiting for job requests on their apps. This “on-call” time, although unpaid, is necessary to remain available for the algorithm’s job dispatches and represents a hidden labor cost rarely accounted for in official earnings or employment statistics.

The study also highlighted the limited autonomy and increased isolation experienced by local gig workers compared with their remote counterparts. While around two-thirds of riders and drivers indicated they could step away from work during hours or select tasks, only a minority of these workers enjoyed the same kind of flexibility reported by 86% to 92% of remote gig workers. Further, under half of local platform workers rarely or never interact with others in their field, whereas remote workers report significantly higher levels of social isolation. These social dimensions of gig work contribute to mental health vulnerabilities and highlight the fragmented experiences of platform labor.

The researchers’ effort to capture experiences of a diverse workforce involved tailored outreach strategies, including multilingual surveys in Polish, Spanish, and Bengali, reflecting the demographic realities of gig workers who are often recent migrants. This inclusivity allowed for a more representative and nuanced understanding of how gig work impacts different communities and demographics within the UK.

Accompanying the survey data, qualitative interviews with delivery drivers in Cambridge illuminated the human side of the statistics. Drivers described the physical pain and exhaustion that accumulate over days of intense work, compounded by the need to meet daily income minimums just to cover basic living costs. The ambiguity and flux inherent in gig work mean that workers feel compelled to operate across multiple app platforms simultaneously, increasing stress and physical strain. These testimonies underline the urgency of regulatory interventions to address wage floors, health and safety protections, and fair working conditions.

The study draws attention to the contradictions embedded in platform labor: app-based companies often brand themselves as innovative “tech firms,” distancing themselves from traditional employer responsibilities and obligations. Yet, in reality, these platforms exert a high degree of control over work rhythms, conditions, and pay, governing labor through sophisticated algorithmic systems without guaranteeing rights or protections. This paradox exposes a fundamental fault line in the modern labor market, where digital management supplants human managerial oversight, exacerbating precarity for workers.

Moreover, the research emphasizes that classifying gig workers as self-employed fails to capture the economic dependency many hold on these platforms. Many workers do not have diversified income sources, making them vulnerable to exploitative dynamics traditionally associated with employment relationships. The lack of employer responsibility in these non-standard work arrangements means that workers endure wage insecurity and absence of social benefits, intensifying inequality and social risk.

As gig economy platforms proliferate, understanding the variable nature of job quality across different forms of platform work becomes increasingly critical. This study serves as a clarion call to policymakers, labor advocates, and platform operators to seriously consider the multifaceted challenges facing gig workers. The interplay of algorithmic algorithmic governance, precarious income, health risks, and psychosocial anxieties must be addressed through comprehensive labor standards, minimum wage guarantees, and effective worker protections.

Ultimately, the Cambridge-led research offers a sobering account of the realities behind the gig economy’s glittering veneer of flexibility and technological progress. It reveals that the future of work mediated by platforms is fraught with contradictions and tensions that demand critical engagement. Without meaningful reforms and enforcement, platform labor risks entrenching new forms of economic inequality and social harm, undermining the dignity and wellbeing of those who power this fast-growing sector.

Subject of Research: People
Article Title: Beyond the ‘Gig Economy’: Towards Variable Experiences of Job Quality in Platform Work
News Publication Date: 3-Jun-2025
Web References: http://dx.doi.org/10.1177/09500170251336947
References: Survey study published in Work, Employment and Society journal
Keywords: gig economy, platform work, job quality, algorithmic management, labor precarity, delivery riders, ride-hailing drivers, income insecurity, occupational health, digital surveillance, UK labor market

B-ALL is a pernicious cancer characterized by an overproduction of immature B-cells, a vital component of the immune system responsible for antibody production. These malignant cells proliferate within the bone marrow, crowding out healthy blood cells and disseminating to other organs, including the brain, where they can evade conventional therapies. The disease commonly afflicts children, accounting for about 40% of all childhood cancers, but it also affects adults, in whom treatment outcomes are typically poorer.

Current standard-of-care approaches for B-ALL involve lengthy and intensive chemotherapy protocols spanning over two years, which, while often effective in younger patients, carry profound toxicities. Patients endure severe side effects such as immunosuppression leading to infections, bruising, bleeding, nausea, hair loss, and long-term complications affecting the nervous system, joints, and cardiac function. Alternative therapies like bone marrow transplants and CAR-T cell therapy have emerged but present their own challenges, including severe side effects, high costs, and complex logistics.

In a paper published in Nature Communications, a team led by Dr. Simon Richardson and Professor Brian Huntly has unveiled a promising new strategy employing a combination of two oral agents: venetoclax and inobrodib. Venetoclax, already approved for a related blood malignancy, acute myeloid leukemia (AML), functions by inhibiting the BCL2 protein, a key regulator of apoptosis or programmed cell death in cancerous B-cells. However, venetoclax alone shows inconsistent effectiveness against B-ALL, prompting researchers to explore mechanisms underlying resistance.

Their investigations centered on the CREBBP gene, which when mutated or inactivated, contributes to disease progression and chemotherapy resistance. CREBBP plays a crucial role in cellular metabolism and gene expression regulation. Astonishingly, the team discovered that inactivating CREBBP rewires the fat metabolism pathways within malignant B-cells. This metabolic shift sensitizes cells to death by ferroptosis — a form of programmed cell death distinct from apoptosis. Ferroptosis involves the iron-dependent peroxidation of lipids in cell membranes, which, when unchecked, leads to catastrophic cellular damage and demise.

To exploit this vulnerability, the Cambridge researchers utilized inobrodib, an inhibitor of CREBBP developed by CellCentric, a Cambridge spinout company. Through CREBBP inhibition with inobrodib, the cancer cells undergo metabolic rewiring that diminishes their ability to prevent lipid damage. When combined with venetoclax’s blockade of BCL2, this dual insult induces ferroptotic cell death in B-ALL cells, including those harboring mutations that confer resistance to venetoclax alone.

Experimental models using human and mouse B-ALL cells demonstrated that this combination therapy powerfully eradicated malignant early-stage B-cells. Notably, the therapy maintained effectiveness against genetically resilient leukemia cells, highlighting its potential to overcome existing treatment barriers. Professor Huntly emphasized the significance of these findings, noting that venetoclax and inobrodib have been safely combined in early trials for AML, bolstering hopes for rapid translation into clinical trials for B-ALL patients.

This therapeutic innovation carries several clinical advantages. Because the drugs are administered orally, the treatment paradigm could be less invasive and more convenient than current protocols. Moreover, the selective targeting of cancerous B-cells with this approach suggests fewer off-target effects, potentially sparing patients the debilitating toxicities commonly associated with chemotherapy and immunotherapies like CAR-T cells—the latter of which can irreversibly deplete normal B-cell populations, impairing immune competence.

Dr. Richardson elaborated on the immune implications, explaining that although B-cells are depleted during administration, the body’s capacity to regenerate healthy B-cells should restore immune function post-treatment. This transient effect markedly contrasts with permanent B-cell aplasia seen in CAR-T cell therapies, making venetoclax and inobrodib a potentially safer therapeutic option.

An important economic consideration accompanies this therapeutic prospect. Venetoclax’s patent expiration in the near future is anticipated to reduce its cost substantially through generics, improving accessibility and affordability for patients and healthcare systems alike. Such developments could democratize use and alleviate financial burdens associated with novel cancer therapies.

The urgency for improved B-ALL therapies is underscored by the real-life experience of survivors like Gill Murphy, who endured aggressive chemotherapy and stem cell transplant for her disease. Her story reveals the profound physical and psychological toll of current treatments, including prolonged hospitalizations and enduring side effects such as fatigue, early menopause, and cognitive challenges. Murphy’s testimony provides a poignant backdrop for the pressing need to develop more tolerable and effective treatments.

Cancer researchers have long sought strategies that not only eliminate malignant cells but also minimize collateral damage to patients’ quality of life. The Cambridge team’s discovery of ferroptosis induction via CREBBP inactivation, combined with BCL2 inhibition, represents a breakthrough in this quest. By harnessing the cancer cell’s metabolic liabilities, this approach exploits a previously untapped cell death pathway, broadening therapeutic horizons.

Despite the promising preclinical data, rigorous clinical trials are essential before this dual-drug approach can become standard treatment. The researchers are actively pursuing funding to initiate clinical trials involving adults and teenagers with B-ALL. Success in these trials could herald a new era of cancer treatment that balances efficacy with safety and patient well-being.

Beyond B-ALL, this research might also illuminate the role of ferroptosis in other hematologic malignancies and solid tumors, inspiring novel drug combinations that trigger ferroptotic cell death in resistant cancers. As scientists deepen understanding of cancer metabolism and cell death pathways, such targeted treatments could transform oncological care globally.

In conclusion, the combination of venetoclax and inobrodib leverages cutting-edge insights into genetic mutations and metabolic reprogramming to strike at the heart of B-ALL survival mechanisms. Its promise lies not only in potentially overcoming drug resistance but in offering a gentler, more precise treatment pathway that could improve survival while mitigating the physical and emotional burdens endured by patients. As research progresses, hopes rise for a future where blood cancers like B-ALL are not just treatable but conquered with compassion and precision.

Subject of Research: Animals

Article Title: CREBBP inactivation sensitizes B cell Acute Lymphoblastic Leukemia to Ferroptotic Cell Death upon BCL2 Inhibition

News Publication Date: 20-May-2025

Web References: 10.1038/s41467-025-59531-6

References: Garcia-Gimenez, A, et al. CREBBP inactivation sensitizes B cell Acute Lymphoblastic Leukemia to Ferroptotic Cell Death upon BCL2 Inhibition. Nat Comms; 20 May 2025; DOI: 10.1038/s41467-025-59531-6

Keywords: Blood cancer, Leukemia, Cancer

The essence of this novel semiconductor lies in its ability to emit circularly polarized light, a trait that enables the transfer of information regarding the "handedness" of electrons. In contrast to traditional inorganic semiconductors, such as silicon, which exhibit symmetrical properties leading to non-directional electron movement, this innovative semiconductor harnesses the chiral characteristics of molecules. Chiral molecules, which can be thought of as mirror images, are prevalent in nature and play crucial roles in biological processes like DNA synthesis. Yet, leveraging this chirality within electronics has historically posed a challenge.

Through the integration of biophilic design principles into molecular architecture, the researchers succeeded in crafting a chiral semiconductor. This was accomplished by guiding stacks of semiconducting molecules to organize into either right-handed or left-handed spiral configurations. The findings from their research have been published in the prestigious journal Science, showcasing not just a notable academic achievement but also an important milestone for future technology.

One of the most promising applications for these chiral semiconductors is their use in display technology. Current display screens are notorious for wasting energy due to inefficiencies in light filtering processes. The chiral semiconductor introduced by these researchers naturally generates light in an orientation that could significantly mitigate such losses, thereby enhancing screen brightness and energy efficiency. This leap forward has profound implications, particularly as the demand for more sustainable technologies continues to grow.

Professor Sir Richard Friend, who collaborated in leading this innovative research from Cambridge’s Cavendish Laboratory, recounted, “When I began my journey with organic semiconductors, many remained skeptical about their potential. However, it is undeniable that they now form the backbone of display technology.” Highlighting the versatility of molecular materials, he likened the freedom to design unique structures to working with a limitless set of building blocks—a stark contrast to the constraints often imposed by rigid inorganic counterparts.

At the heart of this new semiconductor lies a material called triazatruxene (TAT), which self-assembles into a helical configuration, subsequently allowing electrons to spiral effectively along its structure. When stimulated by blue or ultraviolet light, this arrangement causes TAT to emit bright green light, characterized by strong circular polarization. Achieving such an effect in semiconductors had been a formidable challenge until this recent breakthrough, as articulated by Marco Preuss, co-first author from the Eindhoven University of Technology.

Through innovative adaptations in OLED fabrication techniques, the research team successfully integrated TAT into functional circularly polarized OLEDs (CP-OLEDs). These cutting-edge devices exhibited record levels of efficiency, brightness, and polarization, setting a new benchmark in the field. Co-first author Rituparno Chowdhury remarked, “By reengineering the conventional process for manufacturing OLEDs as we employ in smartphones, we’ve discovered a practical method for trapping a stable chiral structure within a non-crystallizing matrix.”

This research is culminative of a prolonged partnership between Sir Richard Friend’s research group and the team of Professor Bert Meijer from the Eindhoven University of Technology. Meijer commented on the significance of their collaboration by stating, “This breakthrough in developing a chiral semiconductor illustrates our meticulous approach to molecular design. We have successfully linked the chirality of our molecular structure to the electrons’ movement—a feat never previously accomplished on this scale.”

The implications of these chiral semiconductors extend far beyond display technologies. Envisioning a future driven by efficient quantum computing and advanced spintronics, these organic materials represent a crucial step forward in evolving electronic mechanisms. Within the growing $60 billion industry of organic semiconductors, this development signifies a turning point that may enhance not only the way we interact with technologies but also how we harness and process information.

Moreover, the work received substantial support from initiatives including the European Union’s Marie Curie Training Network and the European Research Council. Aided by this backing, the researchers are optimistic about tackling the forthcoming challenges and barriers that lie ahead in this rapidly advancing field.

This remarkable research, encapsulating years of collaboration and dedicated inquiry, has not only contributed to a burgeoning field of study but has also provided the scientific community with fresh insights into organic electronics. As the quest for optimizing performance and sustainability in electronic devices continues, this chiral semiconductor promises to be at the forefront of innovation, rooting its significance deeply in the evolution of future technologies.

In summary, this innovative leap in the domain of organic semiconductors enriches our understanding of electronics, presenting exciting potential for the future. By leveraging the intricate properties of molecular chirality, researchers are setting the stage for advanced applications that could redefine our approach to electronics and information technology, heralding in a new era characterized by efficiency and effectiveness.

Subject of Research: Chiral Semiconductors
Article Title: Circularly polarized electroluminescence from chiral supramolecular semiconductor thin films
News Publication Date: 14-Mar-2025
Web References: DOI Link
References: Science Journal
Image Credits: Samarpita Sen/Rituparno Chowdhury

Keywords

Organic semiconductors, display technology, light emitting diodes, molecular electronics, quantum computing, spintronics, semiconductors.

This novel solar-powered reactor stands in stark contrast to traditional carbon capture technologies, which typically rely on fossil fuels for energy input and require complex transport and storage systems for captured CO2. Instead, the Cambridge team has developed a method that utilizes atmospheric CO2, transforming it into syngas—an essential precursor for producing a wide array of chemicals and fuels—thereby opening up new avenues for sustainable energy generation. By eliminating the need for fossil fuel-dependent processes, the researchers have taken a significant step toward mitigating the climate crisis.

The implications of this research extend beyond mere energy production; they address the urgency to find sustainable alternatives as the world grapples with the consequences of climate change. The current reliance on Carbon Capture and Storage (CCS) has its drawbacks, primarily due to its energy-intensive nature and the long-term risks associated with storing pressurized CO2 underground. Cambridge researcher Professor Erwin Reisner articulates these concerns, pointing out the paradox where CCS can inadvertently create a dependency on fossil fuels, the very source of the climate crisis.

Highlighting the innovative essence of this research, Dr. Sayan Kar, the study’s lead author, emphasizes that instead of merely storing harmful CO2, they are transforming it into valuable chemical products. By effectively turning a waste product into a resource, there exists an opportunity not just for pollution reduction but for the creation of a circular economy, where materials are continuously reused rather than disposed of. This perspective shifts the narrative from CO2 as a mere pollutant to its potential as a feedstock for essential chemicals and fuels.

The technological process employed by the Cambridge team mimics the natural phenomenon of photosynthesis, using sunlight to convert CO2 from the air into syngas, a critical intermediate in fuel production. The reactor operates by capturing atmospheric CO2 using specialized filters during the night and initiating a transformation process upon exposure to sunlight when the captured CO2 is heated, generating solar syngas. This heating process activates a chemical reaction, enabling the conversion of CO2 into syngas through adept utilization of sunlight, demonstrating a highly efficient method of energy conversion.

Notably, the reactor’s design incorporates concentrated sunlight through a mirror system, boosting the efficiency of the entire process. The research team aims to build upon this prototype by advancing towards a larger-scale version capable of producing liquid fuels. This progress is essential for practical applications, ultimately providing an eco-friendly alternative to fossil fuels for powering vehicles, aircraft, and numerous other industries reliant on conventional energy sources.

As the world increasingly seeks solutions to combat climate change, researchers at Cambridge underscore the dual benefit of their innovation: removing CO2 from the atmosphere while producing high-demand fuels. If this technology is commercialized successfully, it offers potential for decentralized energy production, allowing individuals in remote areas or off-grid settings to potentially generate their own fuel sustainably.

Moreover, the syngas produced by the reactor opens up possibilities in the chemical and pharmaceutical sectors, where it can be employed to manufacture everyday products without contributing to greenhouse gas emissions. The versatility of syngas makes it an invaluable asset in a variety of industrial processes, reinforcing the need for research initiatives that explore and enhance its production from sustainable sources.

The University of Cambridge has initiated commercialization efforts for this promising technology through its commercial arm, Cambridge Enterprise. This collaboration aims to facilitate the transition from laboratory research to practical applications, which could include partnerships with industries eager to adopt sustainable practices in fuel production. The commitment to pursuing viable market strategies demonstrates a significant advancement toward the practical implementation of carbon-negative technologies.

Research like this not only carries the promise of meeting energy demands but also represents a critical juncture in the broader discourse around sustainability and climate action. By emphasizing the creation of useful products from CO2, the team fosters a narrative of hope and innovation, inspiring further research into technologies that can fundamentally change our relationship with greenhouse gases. Embracing such transformational approaches may provide a pathway to a more sustainable and circular economic model, significantly reducing reliance on fossil fuels.

The findings from this study, soon to be published in the prestigious journal Nature Energy, capture not just a technological advancement but also a holistic approach to solving interconnected global challenges. As the energy landscape continues to evolve, such contributions will be vital in shaping public perception and policy towards greener alternatives. The potential for widespread adoption of this technology could redefine energy consumption patterns, ushering in an era of reduced emissions and sustainable growth.

As nations across the globe grapple with ambitious targets for carbon reduction and climate resilience, the implications of this research could resonate far beyond academia. The successful translation of this technology into practical applications can significantly escalate efforts to combat climate change by providing scalable solutions that address both energy needs and environmental responsibilities.

In conclusion, the collaborative work spearheaded by researchers at the University of Cambridge marks a significant landmark in the pursuit of sustainable fuel production. Their innovative approach, capturing CO2 directly from the air, highlights an exciting frontier in energy technology, promising to reshape how society thinks about carbon emissions and energy sources. Should this research reach its potential, it could serve as a cornerstone for a sustainable future where energy production aligns with ecological integrity and societal welfare.

Subject of Research: Direct air capture of CO2 and conversion to solar fuels
Article Title: Direct air capture of CO2 for solar fuels production in flow
News Publication Date: 13-Feb-2025
Web References: Nature Energy – DOI: 10.1038/s41560-025-01714-y
References: Nature Energy Journal
Image Credits: Credit: University of Cambridge

Keywords: Carbon capture, Fossil fuels, Pharmaceuticals, Energy, Renewable energy, Solar energy